Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELOBiotechnology
-$0.04 today
- Market cap
- $50.84M
- Beta
- -0.24
- P/E (TTM)
- -3.8
- EPS (TTM)
- -$0.27
Volume 0.17M
Average 0.13M
Balance Sheet
Inspect the capital base behind the business.
Assets
$7.34M
FY 2025 · Annual
+454.5% YoYLiabilities
$1.43M
FY 2025 · Annual
+109.7% YoYEquity
$5.91M
FY 2025 · Annual
+819.6% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $5.6M |
| Other Current | $229.0K |
| Total Current Assets | $5.8M |
| Total Assets | $5.8M |
Analysis
Selected assets total $5.8M for Latest. The largest visible component is Cash & Equivalents at $5.6M, about 96.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| S-3 | S-3 filing | Oct 27, 2026 | |
| 8-K | Current report | Oct 6, 2026 | |
| 8-K | Current report | Sep 17, 2026 | |
| 8-K | Current report | Sep 16, 2026 | |
| 8-K | Current report | Sep 14, 2026 |
How much cash does TELO have?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported $7.29M in cash and equivalents in fiscal 2025.
How much debt does TELO carry?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported $473,752.00 of total debt, with net debt of -$6.81M.
Continue the stock analysis
Jump to another research area for this company.